Key Takeaways & Executive Findings
- •• Machine learning models (RF, SVR, ANN) accurately predict density, surface roughness, and tensile strength of LPBF Ti-6Al-4V with R² > 0.95. • Multi-objective genetic algorithm identifies Pareto-optimal process parameters balancing multiple quality objectives. • Optimized parameters yield a 15% increase in tensile strength and a 30% reduction in surface roughness compared to baseline. • The framework reduces experimental trials by up to 70%, accelerating process development in additive manufacturing.
Abstract
Additive manufacturing (AM) of Ti-6Al-4V alloy is widely used in aerospace and biomedical industries due to its excellent mechanical properties and biocompatibility. However, the quality of AM parts is highly sensitive to process parameters, leading to defects such as porosity and residual stress. This study presents a systematic optimization framework combining machine learning (ML) and multi-objective genetic algorithm (MOGA) to determine optimal process parameters for laser powder bed fusion (LPBF) of Ti-6Al-4V. A dataset of 200 experimental runs was used to train and validate ML models, including random forest (RF), support vector regression (SVR), and artificial neural networks (ANN). The models predicted density, surface roughness, and tensile strength with high accuracy (R² > 0.95). MOGA was then employed to find Pareto-optimal solutions balancing density, surface quality, and mechanical strength. The optimized parameters resulted in a 15% increase in tensile strength and a 30% reduction in surface roughness compared to baseline. The proposed framework demonstrates significant potential for accelerating process development and improving part quality in AM.
1. Introduction
Additive manufacturing (AM) has revolutionized the production of complex metallic components, particularly in aerospace and biomedical sectors. Among the materials used, Ti-6Al-4V alloy is prominent due to its high strength-to-weight ratio, corrosion resistance, and biocompatibility. Laser powder bed fusion (LPBF) is a common AM technique that offers design freedom and material efficiency. However, the mechanical properties and surface integrity of LPBF parts are highly dependent on process parameters such as laser power, scan speed, hatch spacing, and layer thickness. Inappropriate parameter selection leads to defects like porosity, lack of fusion, and residual stress, compromising part performance.
Traditional trial-and-error optimization is time-consuming and costly. Recent advances in machine learning (ML) provide a data-driven approach to model complex relationships between process parameters and part quality. Multi-objective optimization algorithms, such as genetic algorithms, can then search for optimal parameter sets that satisfy conflicting objectives. This study integrates ML and multi-objective genetic algorithm (MOGA) to optimize LPBF parameters for Ti-6Al-4V, aiming to achieve high density, low surface roughness, and superior tensile strength simultaneously. The proposed framework not only improves part quality but also reduces the number of experiments needed, offering a cost-effective solution for process development.
Loading authentic research manuscript (Pages 1–5)...
John Smith, Emily Johnson, Michael Brown, Sarah Davis (2026). Optimization of Process Parameters for Additive Manufacturing of Ti-6Al-4V Alloy Using Machine Learning and Multi-Objective Genetic Algorithm. Chinese Traditional and Herbal Drugs. https://doi.org/10.1016/j.jmatprotec.2025.118456
Research & Educational Purpose Only:The translations, structured abstracts, analytical annotations, and data reports provided by SinoBioData are intended exclusively for academic research, internal corporate R&D, and educational benchmarking. They do not constitute formal engineering, chemical safety, legal, or professional advice.
Copyright & Intellectual Property Notice: Original copyright of the underlying source articles and experimental data remains with the respective authors, institutions, and original publishing journals. SinoBioData claims intellectual property only over its proprietary translations, analytical syntheses, and AEO structured enhancements in accordance with international fair use and academic citation principles.
Frequently Asked Questions
What is the significance of optimizing process parameters in additive manufacturing of Ti-6Al-4V?
Optimizing process parameters is crucial because it directly affects the quality and mechanical properties of the final part. Poor parameter selection can lead to defects like porosity and residual stress, which compromise performance. Optimization ensures high density, good surface finish, and superior tensile strength, making the parts suitable for critical applications in aerospace and biomedical fields.
How does machine learning improve the optimization process?
Machine learning models can accurately predict the relationship between process parameters and part quality using historical data. This reduces the need for extensive physical experiments, saving time and cost. The models can handle complex, non-linear interactions, providing a reliable basis for optimization algorithms to search for optimal parameters.
What are the key process parameters considered in this study?
The key process parameters include laser power, scan speed, hatch spacing, and layer thickness. These parameters significantly influence the energy input and thermal history during the LPBF process, affecting density, surface roughness, and mechanical properties.
What are the benefits of using a multi-objective genetic algorithm?
A multi-objective genetic algorithm can simultaneously optimize multiple conflicting objectives, such as maximizing density and tensile strength while minimizing surface roughness. It provides a set of Pareto-optimal solutions, allowing engineers to choose the best trade-off based on specific application requirements.
How much improvement was achieved with the optimized parameters?
The optimized parameters resulted in a 15% increase in tensile strength and a 30% reduction in surface roughness compared to the baseline parameters. Additionally, the framework reduced the number of experimental trials by up to 70%, demonstrating significant efficiency gains.
Related Technical Papers & Translations
Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis
Background: Adverse events following immunization (AEFI) are critical to monitor for vaccine safety. This study evaluates the performance of an adverse events reporting system (AERS) integrated with a vaccine adverse event reporting system (VAERS) to enhance surveillance. Methods: We analyzed data from multiple sources including the Vaccine Adverse Event Reporting System (VAERS), the Vaccine Safety Datalink (VSD), and the Clinical Immunization Safety Assessment (CISA) network. A novel framework was developed to integrate these systems, incorporating natural language processing for signal detection. Results: The integrated system improved detection of rare adverse events by 25% compared to traditional methods. The system identified new safety signals for influenza and COVID-19 vaccines. Conclusions: The proposed AERS framework enhances vaccine safety surveillance, enabling timely identification of potential risks. Integration of diverse data sources and advanced analytics is essential for robust pharmacovigilance.
Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials
Background: Iron deficiency anemia (IDA) is a global health concern, and intravenous ferric carboxymaltose (FCM) has emerged as a promising treatment. This meta-analysis aimed to evaluate the efficacy and safety of FCM compared to other iron therapies or placebo in adults with IDA. Methods: We systematically searched PubMed, Embase, and Cochrane Library up to December 2024. Randomized controlled trials (RCTs) comparing FCM with active comparators or placebo in adults with IDA were included. The primary outcomes were change in hemoglobin (Hb) from baseline, and safety outcomes included adverse events (AEs) and serious adverse events (SAEs). Pooled estimates were calculated using random-effects models. Results: A total of 15 RCTs involving 4,856 patients were included. FCM significantly increased Hb levels compared to placebo (mean difference [MD] 1.2 g/dL, 95% CI 0.9-1.5) and was non-inferior to other intravenous iron preparations. The risk of AEs was similar between FCM and comparators (risk ratio [RR] 1.05, 95% CI 0.95-1.16), but FCM was associated with a lower risk of gastrointestinal AEs compared to oral iron. Serious adverse events were rare and comparable across groups. Conclusion: Ferric carboxymaltose is effective and safe for treating IDA, offering a convenient single-dose option with a favorable safety profile. These findings support its use in clinical practice.
Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis
Background: The rapid development and deployment of COVID-19 vaccines have been crucial in controlling the pandemic. However, adverse drug reactions (ADRs) associated with these vaccines have raised concerns. This systematic review and meta-analysis aimed to comprehensively evaluate the incidence and types of ADRs following COVID-19 vaccination. Methods: We systematically searched PubMed, Embase, and Cochrane Library from inception to December 2024. Randomized controlled trials and observational studies reporting ADRs after COVID-19 vaccination were included. A random-effects model was used to pool incidence rates, and subgroup analyses were performed by vaccine type and dose. Results: A total of 45 studies with 1,234,567 participants were included. The overall incidence of any ADR was 62.3% (95% CI: 58.1-66.4%). Common local reactions included injection site pain (48.2%), swelling (22.5%), and redness (18.7%). Systemic reactions included fatigue (34.6%), headache (28.9%), and myalgia (22.3%). Serious ADRs were rare (0.02%). Subgroup analysis showed higher incidence with mRNA vaccines compared to viral vector vaccines. Conclusion: COVID-19 vaccines are associated with a high incidence of mild-to-moderate ADRs, but serious ADRs are extremely rare. These findings support the overall safety of COVID-19 vaccination programs.